PD-L1/STING conjugates and methods of use
US11596692B1 · kind B1 · utility
8Cited by
1References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2019 |
| Grant date | Mar 7, 2023 |
| Priority date | — |
| Expiry date | May 10, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to conjugates of STING agonists and small molecule modulators of the PD-1/PD-L1 protein/protein interaction, as well as methods of treating cancer using the conjugates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.